Page last updated: 2024-12-07

9,10-epoxy-9,10-dihydrophenanthrene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

9,10-epoxy-9,10-dihydrophenanthrene: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID104975
CHEMBL ID48158
CHEBI ID25957
SCHEMBL ID14870743
MeSH IDM0135119

Synonyms (26)

Synonym
phenanthrene, 9,10-dihydro-9,10-epoxy-
9,10-epoxy-9,10-dihydrophenanthrene
1a,9b-dihydro-1-oxa-cyclopropaphenanthrene
9,10-dihydro-9,10-epoxyphenanthrene
1a,9b-dihydrophenanthro[9,10-b]oxirene
CHEBI:25957 ,
phenanthrene 9,10-oxide
1a,9b-dihydro-1-oxa-cyclopropaphenanthrene
phenanthrene-9,10-epoxide
9,10-epoxy-9,10-dihydro-phenanthrene
phenanthro(9,10-b)oxirene, 1a,9b-dihydro-
9,10-phenanthrene oxide
1a,9b-dihydrophenanthro(9,10-b)oxirene
ccris 1986
phenanthrene-9,10-oxide
585-08-0
CHEMBL48158
AKOS006279295
1a,9b-dihydrophenanthro[9,10-b]oxiren
SCHEMBL14870743
9,10- dihydro-9,10-epoxy-phenanthren
phenanthro[9,10-b]oxirene, 1a,9b-dihydro-
PXPGRGGVENWVBD-UHFFFAOYSA-N
phenanthrene 9, 10-oxide
Q27109898
DTXSID201004762

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" One of the diastereoisomeric forms of the methyl ester of the mercapturic acid is identical with the ester of the mercapturic acid excreted by rats dosed with the epoxide or by rats and rabbits dosed with phenanthrene."( METABOLISM OF POLYCYCLIC COMPOUNDS. THE METABOLISM OF 9,10-EPOXY-9,10-DIHYDROPHENANTHRENE IN RATS.
BOYLAND, E; SIMS, P, 1965
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenanthrene oxide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (40.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.20 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]